Laboratorios Farmaceuticos Rovi (41L) Ownership - Who Owns Laboratorios Farmaceuticos Rovi?
Laboratorios Farmaceuticos Rovi (41L) Ownership Overview
- 2.61% Mutual Funds
- 2.66% ETFs
- 94.72% Public Companies and Individual Investors
The ownership structure of Laboratorios Farmaceuticos Rovi (DE:41L) stock is a mix of institutional, retail, and individual investors. Approximately 5.28% of the company’s stock is owned by Institutional Investors, and 94.72% is owned by Public Companies and Individual Investors.
The ownership structure of Laboratorios Farmaceuticos Rovi (DE:41L) stock is a mix of institutional, retail, and individual investors. Approximately 5.28% of the company’s stock is owned by Institutional Investors, and 94.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| T. Rowe Price International Funds, Inc. | 559,980 | Institution | 1.09% | 39,149,882 |
| Vanguard | 530,467 | Institution | 1.04% | 37,086,539 |
| Ishares | 378,444 | Institution | 0.74% | 26,458,155 |
| Vanguard Star Funds | 244,917 | Institution | 0.48% | 17,122,882 |
| Dfa Investment Dimensions Group Inc | 208,971 | Institution | 0.41% | 14,609,790 |
| Vanguard Tax-managed Funds | 161,441 | Institution | 0.32% | 11,286,825 |
| Vanguard International Equity Index Funds | 116,880 | Institution | 0.23% | 8,171,431 |
| Amundi | 85,946 | Institution | 0.17% | 6,008,743 |
| Dimensional | 77,703 | Institution | 0.15% | 5,432,450 |
| Xtrackers | 50,106 | Institution | 0.10% | 3,503,061 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| T. Rowe Price International Funds, Inc. | 559,980 | Institution | 1.09% | 39,149,882 |
| Vanguard Star Funds | 244,917 | Institution | 0.48% | 17,122,882 |
| Dfa Investment Dimensions Group Inc | 208,971 | Institution | 0.41% | 14,609,790 |
| Vanguard Tax-managed Funds | 161,441 | Institution | 0.32% | 11,286,825 |
| Vanguard International Equity Index Funds | 116,880 | Institution | 0.23% | 8,171,431 |
| Thrivent Mutual Funds | 11,036 | Institution | 0.02% | 771,560 |
| Fidelity Salem Street Trust | 10,638 | Institution | 0.02% | 743,734 |
| T. Rowe Price Global Allocation Fund, Inc. | 4,987 | Institution | <0.01% | 348,656 |
| Fidelity Concord Street Trust | 4,894 | Institution | <0.01% | 342,154 |
| State Street Institutional Investment Trust | 4,490 | Institution | <0.01% | 313,909 |
FAQ
What percentage of Laboratorios Farmaceuticos Rovi (DE:41L) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.28% of Laboratorios Farmaceuticos Rovi (DE:41L) stock is held by institutional investors: 2.61% by mutual funds and 2.66% by ETFs.
What percentage of Laboratorios Farmaceuticos Rovi (DE:41L) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.72% of Laboratorios Farmaceuticos Rovi (DE:41L) stock is held by public companies and individual investors.
Who owns the most shares of Laboratorios Farmaceuticos Rovi (DE:41L)?
T. ROWE PRICE INTERNATIONAL FUNDS, INC. owns the most shares of Laboratorios Farmaceuticos Rovi (DE:41L).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
